The CEO of eGenesis elaborates on today's Nature paper using pig kidneys for transplantation in NHPs

blonca9
Oct 11, 2023
1 min read

Mike Curtis explains how transplanted pig kidneys have shown durability (over two years) in some non-human primates, describes the science behind the gene editing techniques that made it possible, and talks about when this might be tested next in humans.

Nature Paper Link: Design and testing of a humanized porcine donor for xenotransplantation

Recent Posts

See All

On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73

Siren Biotechnology is using an online platform to raise up to $5 million from the public in a "community round" - it might be a new avenue of funding for biotech companies

Theravance Biopharma has a key pivotal trial readout scheduled for late '25 / early '26 in symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA)

The CEO of eGenesis elaborates on today's Nature paper using pig kidneys for transplantation in NHPs

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight